Please log in
You must be logged in to send the contact request.
Manage stand orders
Select Option
Bioneer Corp.
8-11, Munpyeongseo-ro, Daedeok-gu,
34302
Daejeon
Korea, Republic
Korea, Republic
Submit your contact details
Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
Contact
Export Management
Department
Matthew Kim
Sales Manager
International Business Division
International Business Division
Our range of products
Product categories
- 03 Diagnostic tests
- 03.06 Genetic testing, molecular diagnostics
- 03.06.03 Polymerase chain reaction (PCR)
Polymerase chain reaction (PCR)
- Go to BIONEER Virtual booth
- COVID-19 & Influenza A/B simultaneous diagnostic kits
- COVID-19 diagnostic kits
- Protonion™ 48 Viral RNA Kit
- Automatic Nucleic Acid Extractor - ExiPrep™ series
- Viral nucleic acid extraction kits
- Molecular Diagnostics System_ExiStation™ 48/48A
- Molecular Diagnostics System_ExiStation™
- Bioneer’s Newest Real-Time Quantitative Thermal Block_Exicycler™ 96
Our products
Product category: Polymerase chain reaction (PCR)
COVID-19 & Influenza A/B simultaneous diagnostic kits
COVID-19 and influenza symptoms are very similar. Both viruses are transmitted through contact, respiratory droplets, and fomit, but treatment for each disease is different. It is clinically important to distinguish between COVID-19 and influenza with an accurate diagnostic system. This has important implications for the public health measures that can be implemented to respond to each virus.
BIONEER's COVID-19&Influenza simutaneous diagnpstic kits help you to exactly distinguish COVID-19 and Influenza by targeting COVID-19 gene(E gene, RdRp gene, N gene ) and Influenza A/B gene. In addition, 2 types of kits (Premix kit, Master mix kit) help to make it easy to use according to laboratory conditions.
Vacuum dried Premix type
BIONEER's COVID-19&Influenza simutaneous diagnpstic kits help you to exactly distinguish COVID-19 and Influenza by targeting COVID-19 gene(E gene, RdRp gene, N gene ) and Influenza A/B gene. In addition, 2 types of kits (Premix kit, Master mix kit) help to make it easy to use according to laboratory conditions.
Vacuum dried Premix type
- AccuPower® RV1 Real-Time RT-PCR Kit (RV1-1111)
- Specimens : Nasopharyngeal swab, Oropharyngeal swab
- Easy method : Anyone can easily from extraction to Real-time PCR using ExiStation™ and ExiStation™48
- User convenient kit: Pipetting free diagnosis since all components for the assay are contained within a tube.
- AccuPower® RV1 Multiplex Kit (RV1-2112)
- Specimens : Nasopharyngeal swab, Oropharyngeal swab
- Compatible with various system: Exicycler™ 96(BIONEER), CFX 96(Bio-rad), ABI7500Fast(Thermofisher), Quantstudio 5(Thermofisher)
Product category: Polymerase chain reaction (PCR)
COVID-19 diagnostic kits
BIONEER's COVID-19 diagnostic kits are in vitro diagnostics kit for COVID-19 . It can test 3 related genes(E gene, RdRp gene, N gene) in one tube simultaneously for COVID-19 with high specificity and sensitivity. In addition, 2 types of kits (Premix kit, Master mix kit) help to make it easy to use according to laboratory conditions.
Vacuum dried Premix type
Mastermix type
Vacuum dried Premix type
- AccuPower® COVID-19 Multiplex Real-Time RT-PCR Kit (NCVM-1111)
- Specimens : Sputum, Nasopharyngeal swab, Oropharyngeal swab
- Easy Method : Anyone can easily from extraction to Real-time PCR using ExiStation™ and ExiStation™48
- User convenient kit : Pipetting free diagnosis since all components for the assay are contained within a tube.
Mastermix type
- AccuPower® SARS-CoV-2 Multiplex Real-Time RT-PCR Kit (SCVM-2122)
- Specimens : Sputum, Nasopharyngeal swab, Oropharyngeal swab
- Compatible with various system: Exicycler™ 96(BIONEER), CFX 96(Bio-rad), ABI7500Fast(Thermofisher), Quantstudio 5(Thermofisher)
Product category: Polymerase chain reaction (PCR)
Protonion™ 48 Viral RNA Kit
Protonion™ 48 Viral RNA Kit is a viral RNA extract kit designed to minimize turnaround time and compatible with automatic extractor ExiPrep™ 48 Dx. This Kit does not need EtOH, so more accurate diagnosis and fast extraction is possible.
- Specimen : liquid specimen (For COVID-19 : Sputum, Nasopharyngeal & Oropharyngeal swab)
- Starting / Elution volume : 400 ul / 150 ul
- Throughput : 48 samples/run
- Turnaround time : 25 min
Product category: Polymerase chain reaction (PCR)
Automatic Nucleic Acid Extractor - ExiPrep™ series
ExiPrep™ series is an instrument for automatic nucleic acid extraction, and three models are included such as ExiPrep™ 16 Dx, ExiPrep™ 48Dx, ExiPrep™ 96 Lite. You can select ExiPrep™ series depending on your laboratory conditions. ExiPrep ™ series uses pre-filled cartridges to reduce hands-on steps and prevent user errors. In addition, ExiPrep™ 16Dx and ExiPrep™ 48 Dx can be composed of ExiStation™ series with Exicycler™ 96.
ExiPrep™ 16 Dx
ExiPrep™ 16 Dx
- Simultaneous nucleic acid extraction from various types of clinical samples
- Each of 3 ExiPrep™16 Dx extracts different targets at once - Handle Max. 48 samples in 90 min
- Each ExiPrep™16 Dx handles 16 samples in 90 min
- Enhanced usability with built in automatic cartridge puncher
- Various option of sample volume : 200, 400 and 800 ul
- Able to using primary tube by docking ExiLT
- Handle Max. 48 samples in an hour
- Increased space efficiency by compact size
- High through-put and fast
- Handle Max. 96 samples in a run
- Outstanding walkaway time: Approx. 30 min - Flexible sample volume
- 24 test x 4 ml
- 96 test x 0.4 ml
Product category: Polymerase chain reaction (PCR)
Viral nucleic acid extraction kits
ExiPrep™ viral nucleic acid extraction kits are designed for use with automatic nucleic acid extractor, ExiPrep™ series. ExiPrep™ viral nucleic acid extraction kits are the total solutions for accurate and rapid extraction from clinical samples, such as sputum, nasopharyngeal swab, oropharyngeal swab. Extraction kits consists of pre-filled cartridges, reduce hands-on steps and prevente user errors.
ExiPrep™ Dx Viral DNA/RNA Kit (K-4471)
ExiPrep™ Dx Viral DNA/RNA Kit (K-4471)
- Extractor : ExiPrep™16Dx
- Starting volume : 400 ㎕
- Elution volume : 50-100 ㎕
- Throughput : 16 samples/run
- Turnaround Time : 1h 30min
- Extractor : ExiPrep™48Dx
- Starting volume : 400 ㎕ / 800 ㎕
- Elution volume : 50 ㎕
- Throughput : 48 samples/run
- Turnaround Time : 1h
- Extractor : ExiPrep™96 Lite
- Starting volume :200- 400 ㎕
- Elution volume : 100 ㎕
- Throughput : 96 samples/run
- Turnaround Time : 50min
Product category: Polymerase chain reaction (PCR)
Molecular Diagnostics System_ExiStation™ 48/48A
ExiStation™48/48A is the universal molecular diagnostic systems from nucleic acid extraction to real-time PCR.
ExiStation™ 48 is an integrated system consisting of ExiPrep™48 Dx form nucleic acid extraction, and Exicycler™ 96 for Real-Time quantitative thermal block. ExiLT has been added to ExiStation™48A so that the primary tube can be used. ExiStation™ 48/48A can perform nucleic acid extraction and diagnostic tests on 48 samples at the same time. Automatic sample dispensing system is applied to minimize human error through pipetting. In addition, optimized protocols are built in to enhance user convenience.
ExiStation™ 48 is an integrated system consisting of ExiPrep™48 Dx form nucleic acid extraction, and Exicycler™ 96 for Real-Time quantitative thermal block. ExiLT has been added to ExiStation™48A so that the primary tube can be used. ExiStation™ 48/48A can perform nucleic acid extraction and diagnostic tests on 48 samples at the same time. Automatic sample dispensing system is applied to minimize human error through pipetting. In addition, optimized protocols are built in to enhance user convenience.
- Advantage when test some diseases using same type of specimen
- Extract nucleic acids from 48 samples only within an hour.
- Directly use the primary tubes: all processes such as decapping & capping sample tubes and transferring them are fully automated.*
- Automatically input the sample information with the built-in barcode scanner.*
- Control the entire ExiStation™ System from sample preparation to data analysis using ExiStation™ manager software
Product category: Polymerase chain reaction (PCR)
Molecular Diagnostics System_ExiStation™
ExiStation™ is the universal molecular diagnostic systems from nucleic acid extraction to Real-Time PCR. Existation ™ can consist of maximum 3 ExiPrep™ 16 Dx and 1 Exicycler™ 96. So, ExiStation™ can perform nucleic acid extraction and diagnostic tests on 48 samples at the same time and this flexible combination system you can design the most convenient laboratory. All components can be simultaneously operated with different types of samples. Moreover, ExiStation™ has increased reproducibility and convenience through anti-contamination system and pipetting free system.
Product category: Polymerase chain reaction (PCR)
Bioneer’s Newest Real-Time Quantitative Thermal Block_Exicycler™ 96
Exicycler™ 96 is a superior 96-well qPCR system designed for Real-Time PCR applications demanding the highest performance.
- Superior Sensitive Optics by Light Polarization
- Improved Thermal Block Ramp Rate
- Minimization of Ct variation
- Wide Linear Dynamic Range
- Real 5-color Multiplexing
- Excellent Accuracy and Uniformity
- Intuitive & Convenient Software
- Various applications
Company news
Date
Topic
Download
Sep 25, 2020
Bioneer and the Ministry of Health and Welfare of Iraq signed a $2.4 million deal to form a lab for COVID-19 diagnosis
[Daejeon, Republic of Korea – September 25 2020] Bioneer specializing in molecular diagnostics announced that it will build a $2.4 million lab for COVID-19 diagnosis in Iraq
Bioneer signed a turn-key project contract with the Ministry of Health and Welfare of Iraq (MOHW) to set up a laboratory for COVID-19 diagnostic tests. Under this comprehensive $2.4 million contract, Bioneer will supply and set up all the equipment and kits necessary for molecular diagnosis and research.
This contract is the first joint collaboration case between the MOHW and Bioneer's advanced technology and overseas networks. As the result of comprehensive performance evaluation of equipment and kits required for the molecular diagnosis processes from leading global companies, the MOHW of Iraq selected Bioneer products.
Bioneer is the only South Korean biotech manufacturer that provides total molecular diagnostic solutions. Through vertical integration strategy, Bioneer is providing molecular diagnostics technology, instruments and kits from raw materials to final products. The deal with the MOHW of Iraq on laboratory setup and product supply assures the significance and global competitiveness of Bioneer’s products.
Bioneer closely cooperates with its partners across the globe. As a confluent result, this contract is the outcome of advanced coordination and technical activities in Iraq by Bioneer’s local partners the Al-Musaib Bridge Company and Scientific services Bureau.
Bioneer official says that "Although Bioneer has an excellent and innovative technology, our products were less familiar in Iraq till our local partners demonstrated our products to the MOHW of Iraq."
Further it was added that "Indeed, The Foundation for Innovative New Diagnostics (FIND), a strategic partner of WHO, after evaluating Bioneer’s diagnostic kits has delivered results of the highest level in both sensitivity and specificity. Therefore, the MOHW of Iraq has showed strong interest in our products and we are expecting the next contract.”
Meanwhile, “Twindemic” concerns as COVID-19 cases raise and flu season looms. In response, Bioneer has developed a kit that can diagnose both COVID-19 and flu, in order to prevent further pandemics a convergence of the flu and COVID-19. After completing clinical studies, Bioneer is expecting to obtain CE and KFDA certifications.
Bioneer signed a turn-key project contract with the Ministry of Health and Welfare of Iraq (MOHW) to set up a laboratory for COVID-19 diagnostic tests. Under this comprehensive $2.4 million contract, Bioneer will supply and set up all the equipment and kits necessary for molecular diagnosis and research.
This contract is the first joint collaboration case between the MOHW and Bioneer's advanced technology and overseas networks. As the result of comprehensive performance evaluation of equipment and kits required for the molecular diagnosis processes from leading global companies, the MOHW of Iraq selected Bioneer products.
Bioneer is the only South Korean biotech manufacturer that provides total molecular diagnostic solutions. Through vertical integration strategy, Bioneer is providing molecular diagnostics technology, instruments and kits from raw materials to final products. The deal with the MOHW of Iraq on laboratory setup and product supply assures the significance and global competitiveness of Bioneer’s products.
Bioneer closely cooperates with its partners across the globe. As a confluent result, this contract is the outcome of advanced coordination and technical activities in Iraq by Bioneer’s local partners the Al-Musaib Bridge Company and Scientific services Bureau.
Bioneer official says that "Although Bioneer has an excellent and innovative technology, our products were less familiar in Iraq till our local partners demonstrated our products to the MOHW of Iraq."
Further it was added that "Indeed, The Foundation for Innovative New Diagnostics (FIND), a strategic partner of WHO, after evaluating Bioneer’s diagnostic kits has delivered results of the highest level in both sensitivity and specificity. Therefore, the MOHW of Iraq has showed strong interest in our products and we are expecting the next contract.”
Meanwhile, “Twindemic” concerns as COVID-19 cases raise and flu season looms. In response, Bioneer has developed a kit that can diagnose both COVID-19 and flu, in order to prevent further pandemics a convergence of the flu and COVID-19. After completing clinical studies, Bioneer is expecting to obtain CE and KFDA certifications.
Apr 29, 2020
Bioneer supplies $5.7 million worth of COVID-19 related products to Saudi Arabia
[Daejeon, Republic of Korea – April 29, 2020] Bioneer specializing in molecular diagnostics announced that it will supply $5.7 million worth of COVID-19 related products to Saudi Arabia.
Bioneer through High Standard Medical Inc. will distribute COVID-19 related instruments and kits to National Unified Procurement Company, State Enterprise Aramco, and King Fahd Medical Research Centre.
Since obtaining export approval on March 31, Bioneer has been supplying COVID-19 related products to 47 countries, including a $ 1.9 million contract with Romania and a $ 4 million contract with Qatar.
Bioneer through High Standard Medical Inc. will distribute COVID-19 related instruments and kits to National Unified Procurement Company, State Enterprise Aramco, and King Fahd Medical Research Centre.
Since obtaining export approval on March 31, Bioneer has been supplying COVID-19 related products to 47 countries, including a $ 1.9 million contract with Romania and a $ 4 million contract with Qatar.
Apr 7, 2020
Bioneer and Qatar Petroleum singed $4 million Agreement on supply of COVID-19 diagnosis kit and instruments
[Daejeon, Republic of Korea – April 7, 2020] Bioneer (CEO Han-oh Park) specializing in molecular diagnostics announced that it has signed an agreement with Qatar Petroleum, a state-owned company, to supply $4 million worth molecular diagnostic instruments and coronavirus detection kits in Qatar.
Under the agreement, Bioneer will supply Qatar Petroleum with COVID-19 molecular diagnostic kits, nucleic acid extraction reagents and 18 molecular diagnostic instruments such as ExiPrep™ 96 Lite and Exicycler™. Supplied instruments and kits for COVID-19 molecular diagnosis will be applied in medical institutions including the Medical Services Department of Qatar Petroleum.
Bioneer provides a total solution for molecular diagnosis with its gene extraction instrument, real-time PCR instrument, extraction reagents and assays for amplifying and analyzing genes required for COVID-19 detection and diagnostics. All Bioneer’s instruments, reagents and kits are developed by the proprietary technologies in-house.
Under the agreement, Bioneer will supply Qatar Petroleum with COVID-19 molecular diagnostic kits, nucleic acid extraction reagents and 18 molecular diagnostic instruments such as ExiPrep™ 96 Lite and Exicycler™. Supplied instruments and kits for COVID-19 molecular diagnosis will be applied in medical institutions including the Medical Services Department of Qatar Petroleum.
Bioneer provides a total solution for molecular diagnosis with its gene extraction instrument, real-time PCR instrument, extraction reagents and assays for amplifying and analyzing genes required for COVID-19 detection and diagnostics. All Bioneer’s instruments, reagents and kits are developed by the proprietary technologies in-house.
Mar 19, 2020
Bioneer Receives CE Mark for Coronavirus Kits, Inks Supply Agreement in Romania
[Daejeon, Republic of Korea – March. 19, 2020] Bioneer (CEO Han-oh Park) specialized in molecular diagnostics announced that it has signed an agreement in about $1.9 million deal to supply its molecular diagnostic system ExiStation™ and coronavirus detection kits in Romania.
Bioneer recently has received CE-mark certification for ‘AccuPower® COVID-19 Real-Time RT-PCR Kit’ and ‘AccuPower® SARS-CoV-2 Real-Time RT-PCR Kit’.
Bioneer said that it is receiving export inquiries of molecular diagnostic system and COVID-19 kit from many countries in Europe, Southeast Asia, Middle East, etc., and it is discussing the supply in full swing with CE certification.
According to the supply agreement, Bioneer distributes the ExiStation™ and COVID-19 test kits to 20 hospitals designated by the Romanian Ministry of Public Health.
Bioneer recently has received CE-mark certification for ‘AccuPower® COVID-19 Real-Time RT-PCR Kit’ and ‘AccuPower® SARS-CoV-2 Real-Time RT-PCR Kit’.
Bioneer said that it is receiving export inquiries of molecular diagnostic system and COVID-19 kit from many countries in Europe, Southeast Asia, Middle East, etc., and it is discussing the supply in full swing with CE certification.
According to the supply agreement, Bioneer distributes the ExiStation™ and COVID-19 test kits to 20 hospitals designated by the Romanian Ministry of Public Health.
About us
Company details
Bioneer, an innovative biotech company since 1992
Healthier Future for Humanity with Genomic Technology.
Bioneer was the first Korean biotechnology company when it was established in 1992. The company has developed state of art molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation (automatic nucleic acid extractor, thermal cycler, real-time QPCR instruments and DNA sequencer). From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer now runs two production and research facilities in Korea which are a total of 226,000 square feet.
Equipped with proprietary 384 synthesizers, these facilities contain a full production line for oligonucleotide and siRNA synthesis. In addition to DNA manufacturing, Bioneer processes recombinant proteins which are fermented and purified on proprietary purification systems.
After a successful Initial Public Offering a few years ago, Bioneer Corporation launched Bioneer Inc., a wholly owned subsidiary. The American subsidiary is located in a 14,000 square foot production and distribution facility in Alameda, CA, the heart of the San Francisco Bay Area. The company is devoted to providing state of art solutions to the global community of life science researchers in academia, biotech and pharmaceutical companies. We have expertise in a wide range of areas.
Healthier Future for Humanity with Genomic Technology.
Bioneer was the first Korean biotechnology company when it was established in 1992. The company has developed state of art molecular biology products and technologies including oligonucleotides, thermostable polymerases, and instruments of gene manipulation (automatic nucleic acid extractor, thermal cycler, real-time QPCR instruments and DNA sequencer). From its inception, Bioneer has invested in the integration of recombinant DNA technology, fermentation, biochemistry and nucleic acid chemistry in addition to mechanics, photonics and electronics. The company is positioned to fully-integrate its capability to develop next generation technologies in the post-genome era through the invention of new biochemistry and instruments. Bioneer now runs two production and research facilities in Korea which are a total of 226,000 square feet.
Equipped with proprietary 384 synthesizers, these facilities contain a full production line for oligonucleotide and siRNA synthesis. In addition to DNA manufacturing, Bioneer processes recombinant proteins which are fermented and purified on proprietary purification systems.
After a successful Initial Public Offering a few years ago, Bioneer Corporation launched Bioneer Inc., a wholly owned subsidiary. The American subsidiary is located in a 14,000 square foot production and distribution facility in Alameda, CA, the heart of the San Francisco Bay Area. The company is devoted to providing state of art solutions to the global community of life science researchers in academia, biotech and pharmaceutical companies. We have expertise in a wide range of areas.
Company data
Foundation1992.08
Area of business- Laboratory Equipment
- Diagnostics